T2: ANS, Histamine Flashcards
bactericidal drugs
penicillinscephalosporinsaminoglycosidesvancomycinaztreonamimipenemfluroroquinolonesmetronidazolepolymyxinsquinupristin-dalfopristinbacitracin
bacteriostatic drugs
erythromycin (macrolides)clindamycintetracyclinechloramphenicolsulfonamidestrimethoprimnitrofurantoin
narrow spectrum
only G+ or G-: isoniazid against mycobacterium
extended spectrum
G+, some G- i.e. ampicillin
broad spec
wide variety of G+ and G-: tetracycline, chloramphenicol, imipenem
expense of drug administration
IV>IM>oral (cheapest)
drugs that inhibit synthesis of bacterial cell walls: PCN (B-lactam): natural penicillins
G, V Potassium, G Procaine, G Benzathine, G Benzathine + Penicillin G Procaine
drugs that inhibit synthesis of bacterial cell walls: PCN (B-lactam): Penicillinase resistant Penicillins (anti-staph)
methicillinnafcillinoxacillin
drugs that inhibit synthesis of bacterial cell walls: PCN (B-lactam): ext. spec PNC
ampicillinamoxicillin
drugs that inhibit synthesis of bacterial cell walls: PCN (B-lactam): antipseudomonal
Ticarcillin + clavulanate potassium (Timentin)Piperacillin + Tazobactam (Zosyn)
drugs that inhibit synthesis of bacterial cell walls: PCN (B-lactam): monobactams
aztreonam
drugs that inhibit synthesis of bacterial cell walls: PCN (B-lactam): carbapenems
Imipenem + Cilastatin
drugs that inhibit synthesis of bacterial cell walls: PCN (B-lactam): B-lactamase inhibitors
Clavulanic acid, Tazobactam
drugs that inhibit synthesis of bacterial cell walls: cephalosporin (B-lactam): 1st gen
CefazolinCephalexin
drugs that inhibit synthesis of bacterial cell walls: cephalosporin (B-lactam): 2nd gen
CefaclorCefoxitinCefuroximeCefprozil
drugs that inhibit synthesis of bacterial cell walls: cephalosporin (B-lactam): 3rd gen
CeftriaxoneCefiximeCefotaximeCeftazidime
drugs that inhibit synthesis of bacterial cell walls: cephalosporin (B-lactam): 4th gen
Cefepime
drugs that inhibit synthesis of bacterial cell walls: cephalosporin (B-lactam): 5th gen
Ceftaroline
other drugs that inhibit bacterial cell wall synthesis
vancomycinbacitracin
drugs that alter cell membrane permeability
Polymyxin BDaptomycin
drugs that inhibit bacterial protein synthesis: Tetracyclines
short-acting: Tetracycline long-acting: Doxycycline, Minocyclinenew: Tigecycline
drugs that inhibit bacterial protein synthesis: Macrolides
Erythromycin base” Estolate, “ Stearate, “ Ethylsuccinate, “ LactobionateClarithromycinAzithromycinTelithromycin
drugs that inhibit bacterial protein synthesis: Aminoglycosides
Gentamicin; generic: Garamycin, JenamicinTobramycin; generic: NebcinAmikacin; generic: AmikinStreptomycinNeomycin
drugs that inhibit bacterial protein synthesis: Misc.
ClindamycinQuinupristin/DalfopristinLinezolid
act on 50S ribosomal subunit
Cloramphenicol, macrolides, clindamycin, quinupristin/dalfopristin, linezolid
act on 30S ribosomal subunit
Aminoglycosides, Tetracyclines
drugs that act as anti-metabolites: Sulfonamindes
Silver Sulfadiazine (SILVADINE): topicalTrimethoprim-sulfamethoxazole
drugs that inhibit nucleic acid synthesis: Fluoroquinolones
Ciprofloxacin (CIPRO)Levofloxacin (LEVAQUIN)Moxifloxacin (AVELOX)
Misc. drugs that act via nucleic acids
MetronidazoleNitrofurantoinRifampin
empirical therapy
“best guess” therapy, br. spec/combo abxguided by Gs, site of inf, clinical experience, local hospital antibiogram susc. reports-should be changed to rational therapy (narrow spec) when susc. tests performed and org. ID’d
epsilometer (E) test:
also determines MIC, plastic strip containing gradient of known conc. abc placed on agar plate containing pt’s bac. isolate
how to monitor antimicrobial activity in vivo
serum inhibitory titer: greatest dilution of pt’s serum that inhibits visible growth of pt’s infecting pathogenbactericidal titer: plate out above no-growth samples onto abx-free plates
min. drug conc. at infected site should be..
> = MIC, ideally 2-4x MIC(abscesses must be drained)
BBB may prevent..
penetration of drug into CSF-but during infection BBB is diminished (opened up tight junctions of cerebral capillaries)–>inc. penetration
this may prevent abx penetration to site of action (and dec. levels of free drug)
abx binding to plasma proteins
med doses may need to be adjusted for..
renal/hepatic failurenewbornsoral vs. parenteral admin
bactericidal or bacteriostatic?
cidal is better, esp. if immunecomp
strains of these are resistant to all known drugs
EnterococciPseudomonasEnterobacter
bacterial resistance factors
indiscrim. use (misuse)delay in optimal txadmin of subopt. dosetx during dormant stageinability to reach inf. site (CNS, eye, prostate, abscess) defective funct. status of host defense mech agricult. used of abx in livestock
how microorganisms produce resistance
mutation and selection i.e. resistance to:-strep (ribosomal mut.)-quinolone (DNA gyrase)-linezolid (rRNA)-rifampin (RNA polymerase)-M. tuberculosis
resistance mediated by genetic exchange
HGT: transformation (PCN res. in pneumo.)transduction (Staph, penicillinase)conjugation
conjugation
2 sets of genes transferred: R-determinant (resistance) and resistance transfer factor (RTF)–>ind or combine to for R-factor*can have >1 abx resis. gene!**>50% ppl have int. bac containing R-factors
transposon
DNA sequences that can “jump from place to place”, can carry drug resis. genesplasmid–>plasmidplasmid–>chromosome (and vis versa)
biochem mechs of drug resistance
- dec. perm. of org to drug: porins do not allow in anymore (G-) OR active efflux (tetras)2. inactivation of abx by enzymes: (PCN, Chloramphenicol, Aminoglycosides): B-lactamases (+ and -) acetyl/phosphoryl/adenylate drug (amino glycosides, G-)3. altered drug target site: PBP w/ altered affinity for drug, mut. in FQ target (DNA gyrase)
forms of synergism seen with combo abx tx
-block of seq. steps in metabolic pathway (Trimethoprim + Sulfamethosazole–>folic acid)-inhib. enz. inact. of abx (B-lactamase inhibitor)-enhanced abx uptake by bac (aminoglycoside + B-lactam)
synergism
4x or greater reduction in MIC or MBC when drug combined
antagonism
> 50% MIC of each drug needed to produce inhibition of growth
antagonism exs.
bacteriostatic antags. bactericidal (need actively growing org) (PCN + chlortetracycline)induction of enz. inact.: imipenem (induces B-lactamase) + piperacillin (susc. to B-lactamase)
combo abx tx uses
mixed bac infunknown specific cause-empirical tx (i.e. pneumonia: macrolides for M. pneumo + ceftriaxone for G-)synergism may be nec. to kill org. (PCN + AMGS better tx for enterococcal endocarditis)may prevent resistances (bismuth salts + amos/tetra/or clarithro + metronidazole for H. pylori)
disadv. of combo abx tx
inc. toxic side effectsselection of orgs resis. to >1 abxpossible antag. effect if wrong combo
abx ppx
-post-exposure to certain microorgs: gon, syph, anthrax-prevent recurrent dis. in susc. pt: artific. heart valve undergoing dental proc. to prevent bac endocarditis, emphysema pts to prevent chron. bronchitis, frequent UTIs-surgical procedures: 0-2 hrs before, during, 3-4 hrs after-trauma contam wounds
abx ppx approved surgical procedures
contam, clean-contam operations, dirty wounds, prosthetic placement, immune comp host (any proc)
superinfections
new infection appears during chemotx for other infection
why do superinfections occur?
doses of abx can inhibit NF growth–>other orgs uninhibited
superinfection orgs
enterobacteriaceae, pseudomonas, candida, fungi
inc. risk of superinfection w/
brd spec abx, longer course, oral admin over IM/IV
abx misuse
-for viral infection (fever 2 wks which could be tb, intra-abd. abscess, inf. endocarditis, Ca-undetermined cause (NOT antipyretics)-improp. dosage -abx has to reach inf. site (get rid of pus and kidney stones)-lack of adeq. bac info: more testing!-improp. duration of tx (finish your abxs!)
receptors at parasympathetic end organs (and symp. sweat glands)
muscarinic: M1-5, 2,3*most common
B1 adrenergic receptor
heart (inc. force, rate)kidney (mediate renin secr) brain
B2 adrenergic receptor
airway, BVs of skel music, pregnant uterus-smooth musc relaxation
B3 adrenergic receptor
bladder smooth musc: relaxation
a1 adrenergic receptor
most BVs, urinary sphincters, eye-mediate contraction of smooth musc
a2 adrenergic receptor
some end organs, @ adrenergic nerve endings and in CNS
organs that received both parasym and symp innervation
heart, GI, bladder, eye, etc
organs w/ only symp innervation
adrenal medulla, spleen capsule, pilomotor musc, BVs of skin and skeletal muscd
reserpine blocks adrenergic system..
produces exaggerated cholinergic response: inc. GI motility, secretions
atropine blocks cardiac vagal influence..
cardiac acceleration, reduction of GI motility, secretion
eye sympathetics
a1: mydriasis (dilator musc. of iris) B2: inc. aqueous humor
gland sympathetics
a, BB2: respiratory secretions
heart sympathetics
B1, B2:inc. rate (SA node), contractility (ventricles), automaticity, conduction velocity (SA, AV nodes)
BVs sympathetics (mucosa, saliva, skin, splanchnic)
a1, a2: constriction
BVs sympathetics (skeletal musc)
a1: constrictionB2: dilation
BVs parasyms
no PS inn to most vasc beds, but muscarinic rec are present on endo cells: activation of these receptors: NO-med. vasodilation
airway symps
relaxation: B2
GI symps
relaxation: a1, a2, B1, B2 dec. motility
Urinary bladder wall, sphincter, prostate sympathetics
relaxation: B2, B3 (widens out)contraction: a1 (sphinter)
kidney JG cell symp
inc. renin secretion: B1
uterus symp
contraction: a1relaxation: B2 (later on)
male sex organs symp
ejaculation: a1
male sex organs PS
erection
liver, fat cells symp
inc. glucose output: B2inc. FA output: B1
skin pilomotor music and sweat glands symps
contraction: a1secretion: muscarinic